Form D · Biotechnology
EcoGenome LLC
Wynnewood, PA · CIK 0001953248
Offering snapshot reported Nov 4, 2022 · SEC filing
- Reported sold
- $2.03M Offering amount: $2.5M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 19, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 4, 2022 | Initial | $2,025,000 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-463922
Source: Form D, filed Nov 4, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard G Pestell | Executive |
| Mark Waller | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
C/O Lankenau Institute For Med. Research 100 E. Lancaster Ave., Room 234
Wynnewood, PA, 19096
Wynnewood, PA, 19096